JPWO2020099663A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020099663A5 JPWO2020099663A5 JP2021526737A JP2021526737A JPWO2020099663A5 JP WO2020099663 A5 JPWO2020099663 A5 JP WO2020099663A5 JP 2021526737 A JP2021526737 A JP 2021526737A JP 2021526737 A JP2021526737 A JP 2021526737A JP WO2020099663 A5 JPWO2020099663 A5 JP WO2020099663A5
- Authority
- JP
- Japan
- Prior art keywords
- acnes
- roxp
- composition
- strains
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186427 Cutibacterium acnes Species 0.000 claims 32
- 208000020154 Acnes Diseases 0.000 claims 26
- 239000000203 mixture Substances 0.000 claims 24
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 230000036542 oxidative stress Effects 0.000 claims 12
- 230000003248 secreting effect Effects 0.000 claims 12
- 208000002874 Acne Vulgaris Diseases 0.000 claims 11
- 206010000496 acne Diseases 0.000 claims 11
- 208000017520 skin disease Diseases 0.000 claims 11
- 238000000034 method Methods 0.000 claims 10
- 102000004020 Oxygenases Human genes 0.000 claims 8
- 108090000417 Oxygenases Proteins 0.000 claims 8
- 229940055019 propionibacterium acne Drugs 0.000 claims 8
- 239000007921 spray Substances 0.000 claims 8
- 201000004624 Dermatitis Diseases 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 4
- 208000009621 actinic keratosis Diseases 0.000 claims 4
- 239000000443 aerosol Substances 0.000 claims 4
- 239000002537 cosmetic Substances 0.000 claims 4
- 239000006071 cream Substances 0.000 claims 4
- -1 droplets Substances 0.000 claims 4
- 239000006260 foam Substances 0.000 claims 4
- 239000000499 gel Substances 0.000 claims 4
- 239000006210 lotion Substances 0.000 claims 4
- 239000002674 ointment Substances 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 4
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 4
- 239000006228 supernatant Substances 0.000 claims 4
- 238000011200 topical administration Methods 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 3
- 241000101040 Pityriasis Species 0.000 claims 3
- 201000004681 Psoriasis Diseases 0.000 claims 3
- 241001303601 Rosacea Species 0.000 claims 3
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 3
- 208000024780 Urticaria Diseases 0.000 claims 3
- 206010047642 Vitiligo Diseases 0.000 claims 3
- 208000010668 atopic eczema Diseases 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 201000004700 rosacea Diseases 0.000 claims 3
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 3
- 230000005526 G1 to G0 transition Effects 0.000 claims 2
- 230000001332 colony forming effect Effects 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 230000009759 skin aging Effects 0.000 claims 2
- 230000009286 beneficial effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18206646 | 2018-11-16 | ||
| EP18206646.4 | 2018-11-16 | ||
| PCT/EP2019/081546 WO2020099663A1 (en) | 2018-11-16 | 2019-11-15 | Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022507616A JP2022507616A (ja) | 2022-01-18 |
| JPWO2020099663A5 true JPWO2020099663A5 (https=) | 2022-11-16 |
| JP2022507616A5 JP2022507616A5 (https=) | 2022-11-16 |
| JP7532361B2 JP7532361B2 (ja) | 2024-08-13 |
Family
ID=64331864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526737A Active JP7532361B2 (ja) | 2018-11-16 | 2019-11-15 | 酸化ストレスに関連付けられる皮膚疾患及び皮膚老化を処置するための組成物ならびに酸化ストレスに関連付けられる皮膚疾患の診断。 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220000762A1 (https=) |
| EP (1) | EP3880304B8 (https=) |
| JP (1) | JP7532361B2 (https=) |
| KR (1) | KR102913696B1 (https=) |
| CN (1) | CN113038959B (https=) |
| AU (1) | AU2019380669B2 (https=) |
| BR (1) | BR112021008496A2 (https=) |
| CA (1) | CA3118524A1 (https=) |
| ES (1) | ES2994459T3 (https=) |
| MX (1) | MX2021005755A (https=) |
| PL (1) | PL3880304T3 (https=) |
| WO (1) | WO2020099663A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3025685T3 (en) | 2014-06-17 | 2025-06-09 | Crown Laboratories Inc | Genetically modified bacteria and methods for genetic modification of bacteria |
| EP3285872A4 (en) | 2015-04-20 | 2019-02-20 | S-Biomedic NV | METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS |
| WO2017147507A1 (en) | 2016-02-24 | 2017-08-31 | Xycrobe Therapeutics, Inc. | Skin probiotic formulation |
| KR102584057B1 (ko) | 2016-10-19 | 2023-09-27 | 에스-바이오메딕 엔브이 | 박테리아 균주의 복합 혼합물을 사용하여 피부 마이크로바이옴의 조성을 변경하기 위한 방법 및 조성물 |
| CA3183350A1 (en) | 2020-06-23 | 2021-12-30 | Thomas M. Hitchcock | Probiotic skin formulations |
| CN116940330A (zh) * | 2020-12-21 | 2023-10-24 | 南洋理工大学 | 短链脂肪酸作为去屑剂的用途 |
| CN113219097B (zh) * | 2021-01-15 | 2022-06-24 | 杭州海关技术中心 | 婴幼儿配方奶粉中肉碱对映体拆分和测定方法 |
| CA3239122A1 (en) * | 2021-12-17 | 2023-06-22 | S-Biomedic | A freeze-dried composition and preparation thereof |
| EP4197523A1 (en) * | 2021-12-17 | 2023-06-21 | DSM IP Assets B.V. | A freeze-dried composition and preparation thereof |
| KR20240135644A (ko) * | 2022-01-12 | 2024-09-11 | 에스-바이오메딕 엔브이 | 스킨 케어 조성물 및 이의 용도 |
| CN115165819B (zh) * | 2022-05-27 | 2024-08-09 | 天津科技大学 | 一种快速定量分析芦丁的荧光分子印迹光子晶体凝胶条的制备方法及应用 |
| CN120173837B (zh) * | 2025-05-21 | 2025-12-05 | 杭州微致生物科技有限公司 | 痤疮丙酸杆菌vb208基因编辑方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| JP2011037764A (ja) * | 2009-08-11 | 2011-02-24 | Shiseido Co Ltd | 皮膚外用剤、美白剤、抗酸化剤および抗老化剤 |
| FR2954140A1 (fr) * | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
| ITPR20110035A1 (it) | 2011-05-06 | 2012-11-07 | Bormioli Rocco & Figlio Spa | Capsula. |
| CN104364394B (zh) * | 2012-03-17 | 2019-02-22 | 加州大学评议会 | 痤疮的快速诊断和个体化治疗 |
| ITUA20162141A1 (it) | 2016-03-31 | 2017-10-01 | Bormioli Pharma Spa | Capsula di chiusura |
| IT201600097495A1 (it) | 2016-09-28 | 2018-03-28 | Bormioli Pharma S R L | Capsula con struttura di contenimento e rilascio di un prodotto |
| KR102584057B1 (ko) | 2016-10-19 | 2023-09-27 | 에스-바이오메딕 엔브이 | 박테리아 균주의 복합 혼합물을 사용하여 피부 마이크로바이옴의 조성을 변경하기 위한 방법 및 조성물 |
-
2019
- 2019-11-15 AU AU2019380669A patent/AU2019380669B2/en active Active
- 2019-11-15 JP JP2021526737A patent/JP7532361B2/ja active Active
- 2019-11-15 EP EP19800907.8A patent/EP3880304B8/en active Active
- 2019-11-15 KR KR1020217018454A patent/KR102913696B1/ko active Active
- 2019-11-15 BR BR112021008496-7A patent/BR112021008496A2/pt unknown
- 2019-11-15 CN CN201980075535.6A patent/CN113038959B/zh active Active
- 2019-11-15 CA CA3118524A patent/CA3118524A1/en active Pending
- 2019-11-15 MX MX2021005755A patent/MX2021005755A/es unknown
- 2019-11-15 PL PL19800907.8T patent/PL3880304T3/pl unknown
- 2019-11-15 US US17/293,464 patent/US20220000762A1/en active Pending
- 2019-11-15 ES ES19800907T patent/ES2994459T3/es active Active
- 2019-11-15 WO PCT/EP2019/081546 patent/WO2020099663A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020099663A5 (https=) | ||
| BR112021008496A2 (pt) | composições para o tratamento de doenças de pele associadas a estresse oxidativo e envelhecimento da pele e diagnóstico de doenças de pele associadas a estresse oxidativo | |
| EP3334444B1 (en) | Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne | |
| JP2024009822A (ja) | 組換え微生物を用いて炎症性皮膚疾患を処置するための方法および組成物 | |
| US20170360719A1 (en) | Novel method of use | |
| KR20180056775A (ko) | 유산균 함유 조성물 및 아토피 피부염을 치료하기 위한 이의 용도 | |
| Sintov et al. | Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies | |
| KR20160101492A (ko) | 플로레틴의 항여드름 및 항염증 용도 | |
| JP2022501330A5 (https=) | ||
| Seneschal et al. | Alopecia areata: Recent advances and emerging therapies | |
| Aronoff et al. | E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae | |
| Jin et al. | Protective effect of tert-butylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice | |
| Gan et al. | Commensal microbe regulation of skin cells in disease | |
| Oppeltz et al. | Gamma delta (γδ) T-cells are critical in the up-regulation of inducible nitric oxide synthase at the burn wound site | |
| KR102031712B1 (ko) | 그래핀 양자점을 포함하는 항염증용 조성물 | |
| JP2015500820A (ja) | Ｅｇｆｒ阻害の有害反応を予防または処置するための組成物 | |
| Shang et al. | Erythropoietin attenuates lung injury in lipopolysaccharide treated rats | |
| Kim et al. | Superoxide dismutase secreting Bacillus amyloliquefaciens spores attenuate pulmonary fibrosis | |
| JP7219033B2 (ja) | Ｍ．ａｅｒｉｌａｔａを有効成分とする皮膚外用組成物 | |
| JP6758279B2 (ja) | ケモカインを含む皮膚美白用組成物 | |
| KR102433721B1 (ko) | 아토피 피부염을 치료하기 위한 방법 및 조성물 | |
| Kim et al. | Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids | |
| Liao et al. | Echinacoside targets the HIF-1α/LDHA axis to modulate A1/A2 astrocyte differentiation and promote glial scar repair following ischemic stroke | |
| EP3164110B1 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
| TW201711696A (zh) | 用於促進傷口癒合的吳郭魚抗菌胜肽 |